Pharmacogenomics and artificial intelligence in cardiovascular disease: emerging tools for precision medicine.
In conclusion, the integration of pharmacogenetics and artificial intelligence has considerable promise for the enhanced, secure, and individualized management of cardiovascular illnesses.